JACS
NYSE · N/A
Jackson Acquisition Co-Cl A
$10.64
-0.01 (-0.09%)
Open$10.64
Previous Close$10.65
Day High$10.64
Day Low$10.64
52W High$10.73
52W Low$10.25
Volume—
Avg Volume62.5K
Market Cap265.46M
P/E Ratio29.97
EPS$0.30
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.70M | 9.17M | 10.79M |
| Net Income | 1.60M | 1.49M | 1.93M |
| Profit Margin | 16.5% | 16.3% | 17.9% |
| EBITDA | 3.23M | 2.99M | 3.58M |
| Free Cash Flow | 1.53M | 1.89M | 1.86M |
| Rev Growth | +20.0% | +20.7% | -1.4% |
| Debt/Equity | 0.53 | 0.48 | 0.63 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.33 | +0.96% | — | 3.76B |
| PICS | Pics Nv | $11.07 | -1.51% | 6.4 | 1.43B |
| DMII | Drugs Made In America Acquis | $10.09 | +0.20% | 74.9 | 642.73M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.28% | 35.3 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | -0.10% | 57.7 | 594.36M |